Background Active natural ingredients, especially small molecules, have recently received
wide attention as modifiers used to treat neurodegenerative disease by promoting …

Ischemic stroke is the leading cause of death around the world. Ginkgolide K (GK) has been
used to treat ischemic stroke due to its neuroprotective potential. However, the molecular …

Parkinson's disease (PD) is one of the most prevalent and life-threatening
neurodegenerative disease and mainly characterized by lack of sufficient dopaminergic …

Parkinson's disease (PD) is the second most common neurodegenerative disease with a
fast-growing prevalence. Developing disease-modifying therapies for PD remains an …

Ginkgolide B (GB) and ginkgolide K (GK) are two main active monomers of ginkgolides that
present a unique group of diterpenes found naturally in the leaves of the Ginkgo biloba tree …

Huntington's disease (HD) is one of main neurodegenerative diseases, characterized by
striatal atrophy, involuntary movements, and motor incoordination. Ginsenoside Rg1 (Rg1) …

Parkinson's disease (PD) is an age-related neurodegenerative disease for which the
characteristic motor symptoms emerge after an extensive loss of dopamine containing …

Summary Aim Ginkgolide B (GB) has shown neuroprotective effect in treating ischemic
stroke, related to its property of anti‐inflammation. Nevertheless, it is unclear whether GB is …

Abundant evidence has suggested that neuroinflammation participates in the pathogenesis
of Parkinson′ s disease (PD). The emerging evidence has supported that microglia may …

Ginkgolide B (GB), the diterpenoid lactone compound isolated from the extracts of Ginkgo
biloba leaves, significantly improves cognitive impairment, but its potential pharmacological …